Objectives and sub-objectives of Horizon Pharma
The objective of Horizon is to identify, develop, acquire, and commercialize a range of medical products that are accessible and will address different medical needs of the patients. The company is known for producing medicines for treating various diseases like arthritis and inflammatory disorders. It is focusing on developing and commercializing drugs that address treatment needs for unique diseases like rheumatic disorders. Therefore, it aims at innovating medicines that will treat the rare disease in society. The company also has an objective of acquiring DepoMed to enhance its sales and innovation to help produce medications that would help in meeting the treatment needs of the patients. Horizon Pharma has a sub-objective of improving the sales of its medical products to increase the revenue collected from the sale of drugs to the consumers.
Strategies and tactics
The strategies and activities of Horizon Pharma include innovation and growth through acquisition. The acquisition strategy is the growth approach that is generally used by business organizations to acquire a target company to generate value. It typically enables the company to achieve a profitable outcome from acquiring its target firm. Horizon Pharma has successfully employed the strategy to generate more revenue. The result of the strategy is evident by the increased sales of the company’s medicines in various divisions. Innovation strategy, on the other side, is the plan to grow market share or profit through product innovation. Horizon Pharma is engaging in the innovation of new medicines aimed at treating the rare health conditions in society. The drugs would resultantly promote the profit and revenue of the company when released to the market to satisfy the needs of the patients.